Tags

Type your tag names separated by a space and hit enter

Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
Ital J Gastroenterol Hepatol. 1998 Aug; 30(4):363-7.IJ

Abstract

BACKGROUND

The effect of infection by Helicobacter pylori on gastric physiology in duodenal ulcer subjects is controversial. There is evidence that the infection is associated with abnormalities in gastrin homeostasis. Consistent changes in pentagastrin-stimulated acid secretory status have proved difficult to establish. This may be because patients have been studied too soon after Helicobacter pylori eradication.

AIMS

To study the immediate and longer term effect of Helicobacter pylori eradication on basal and pentagastrin-stimulated acid secretion in duodenal ulcer subjects.

PATIENTS AND METHODS

Patients with active duodenal ulcer disease were studied. Ulcers were healed with sucralfate 2 g bd or ranitidine 300 mg nocte. Helicobacter pylori eradication was attempted with bismuth-based "Triple Therapy", and the nine patients in whom the organism was successfully eradicated were followed and studied over the 12-month period. Acid secretion was studied at entry (prior to the initiation of therapy), following healing, following eradication and 12 months later. Basal, low dose (0.1 microgram/kg) and high dose (6 micrograms/kg) pentagastrin-stimulated acid secretion was determined.

RESULTS

Whilst there was a tendency for basal and low dose-stimulated acid secretion to fall following eradication, in this study only the reduction in high dose-stimulated acid secretion achieved significance following eradication (entry mean = 59.6, post eradication mean = 49.6, p < 0.03). This effect of eradication on high dose pentagastrin-stimulated acid secretion was also seen at the 12-month study (mean = 48.9, p < 0.02 versus entry).

CONCLUSION

The findings of this study suggests that maximally stimulated acid secretion is modestly, albeit significantly, reduced following Helicobacter pylori eradication and that this effect persists.

Authors+Show Affiliations

Gastrointestinal Clinic, University of Cape Town, South Africa. japie@uctgsh2.uct.ac.zaNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9789128

Citation

Louw, J A., et al. "Basal and Pentagastrin Stimulated Acid Secretion in Duodenal Ulcer Subjects Before and After Helicobacter Pylori Eradication: a 12-month Follow-up Study." Italian Journal of Gastroenterology and Hepatology, vol. 30, no. 4, 1998, pp. 363-7.
Louw JA, Young GO, Lucke W, et al. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study. Ital J Gastroenterol Hepatol. 1998;30(4):363-7.
Louw, J. A., Young, G. O., Lucke, W., Bridger, S., Winter, T. A., & Marks, I. N. (1998). Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study. Italian Journal of Gastroenterology and Hepatology, 30(4), 363-7.
Louw JA, et al. Basal and Pentagastrin Stimulated Acid Secretion in Duodenal Ulcer Subjects Before and After Helicobacter Pylori Eradication: a 12-month Follow-up Study. Ital J Gastroenterol Hepatol. 1998;30(4):363-7. PubMed PMID: 9789128.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study. AU - Louw,J A, AU - Young,G O, AU - Lucke,W, AU - Bridger,S, AU - Winter,T A, AU - Marks,I N, PY - 1998/10/28/pubmed PY - 1998/10/28/medline PY - 1998/10/28/entrez SP - 363 EP - 7 JF - Italian journal of gastroenterology and hepatology JO - Ital J Gastroenterol Hepatol VL - 30 IS - 4 N2 - BACKGROUND: The effect of infection by Helicobacter pylori on gastric physiology in duodenal ulcer subjects is controversial. There is evidence that the infection is associated with abnormalities in gastrin homeostasis. Consistent changes in pentagastrin-stimulated acid secretory status have proved difficult to establish. This may be because patients have been studied too soon after Helicobacter pylori eradication. AIMS: To study the immediate and longer term effect of Helicobacter pylori eradication on basal and pentagastrin-stimulated acid secretion in duodenal ulcer subjects. PATIENTS AND METHODS: Patients with active duodenal ulcer disease were studied. Ulcers were healed with sucralfate 2 g bd or ranitidine 300 mg nocte. Helicobacter pylori eradication was attempted with bismuth-based "Triple Therapy", and the nine patients in whom the organism was successfully eradicated were followed and studied over the 12-month period. Acid secretion was studied at entry (prior to the initiation of therapy), following healing, following eradication and 12 months later. Basal, low dose (0.1 microgram/kg) and high dose (6 micrograms/kg) pentagastrin-stimulated acid secretion was determined. RESULTS: Whilst there was a tendency for basal and low dose-stimulated acid secretion to fall following eradication, in this study only the reduction in high dose-stimulated acid secretion achieved significance following eradication (entry mean = 59.6, post eradication mean = 49.6, p < 0.03). This effect of eradication on high dose pentagastrin-stimulated acid secretion was also seen at the 12-month study (mean = 48.9, p < 0.02 versus entry). CONCLUSION: The findings of this study suggests that maximally stimulated acid secretion is modestly, albeit significantly, reduced following Helicobacter pylori eradication and that this effect persists. SN - 1125-8055 UR - https://www.unboundmedicine.com/medline/citation/9789128/Basal_and_pentagastrin_stimulated_acid_secretion_in_duodenal_ulcer_subjects_before_and_after_Helicobacter_pylori_eradication:_a_12_month_follow_up_study_ L2 - https://medlineplus.gov/helicobacterpyloriinfections.html DB - PRIME DP - Unbound Medicine ER -